Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
08/17/1995 | WO1995007994A3 Recombinant alphavirus vectors |
08/17/1995 | CA2183260A1 Prolactin as a vaccine adjuvant |
08/17/1995 | CA2182978A1 Peptides and methods against diabetes |
08/17/1995 | CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality |
08/17/1995 | CA2182118A1 Nucleic acid-containing composition, its preparation and use |
08/16/1995 | EP0666929A1 Method of inhibiting replication of hyperproliferative cells |
08/16/1995 | EP0666923A1 Targeted delivery of poly- or oligonucleotides to cells |
08/16/1995 | EP0666914A1 Novel p-selectin ligand protein |
08/16/1995 | EP0666911A1 Multidrug resistance gene |
08/16/1995 | EP0666745A1 Diagnosis and therapy for parkinson's disease |
08/16/1995 | EP0532525B1 New protein-polycation conjugates |
08/15/1995 | US5441875 Urea transporter polypeptide |
08/15/1995 | US5441739 Reduced and controlled surface binding of biologically active molecules |
08/15/1995 | CA1336678C Prophylaxis and treatment of nervous system diseases with melanin |
08/10/1995 | WO1995021380A1 Assay for screening of receptor antagonists |
08/10/1995 | WO1995021259A1 Adenoviral-mediated method of cell transfection |
08/10/1995 | WO1995021253A1 Ets1 gene: a human tumor suppressor gene |
08/10/1995 | WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof |
08/10/1995 | WO1995021195A1 Non-viral vector |
08/10/1995 | WO1995021184A1 Substituted purines and oligonucleotide cross-linking |
08/10/1995 | WO1995021179A1 Endotoxin reduction or removal process |
08/10/1995 | WO1995021178A1 Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions |
08/10/1995 | WO1995021177A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
08/10/1995 | WO1995015373A3 Inhibition of dna methyltransferase |
08/10/1995 | CA2182616A1 Non-viral vector |
08/10/1995 | CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof |
08/09/1995 | EP0666313A2 Targeting of telomerase in cancer gene therapy |
08/09/1995 | EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
08/09/1995 | EP0665739A1 Morphogen-induced periodontal tissue regeneration |
08/03/1995 | WO1995020678A1 Human dna mismatch repair proteins |
08/03/1995 | WO1995020660A2 Immunization by inoculation of dna transcription unit |
08/03/1995 | WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene |
08/03/1995 | WO1995020404A1 Triplex-forming paired-ion oligonucleotides and methods for preparing and using same |
08/03/1995 | WO1995020398A1 Human growth hormone |
08/03/1995 | WO1995012660A3 Recombinant p53 adenovirus methods and compositions |
08/03/1995 | CA2182206A1 Human dna mismatch repair proteins |
08/03/1995 | CA2182205A1 Human growth hormone |
08/03/1995 | CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene |
08/02/1995 | EP0664832A1 Remyelination using neural stem cells |
08/01/1995 | US5437994 Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
07/27/1995 | WO1995020042A1 Embryonic stem cell isolation |
07/27/1995 | WO1995019985A1 Haemopoietic maturation factor |
07/27/1995 | WO1995019799A1 Gas driven gene delivery instrument |
07/27/1995 | WO1995019793A1 Hematopoietic cell expansion and transplantation methods |
07/27/1995 | WO1995019785A1 Treatment for juvenile diabetes |
07/27/1995 | WO1995019769A1 Combinations of a creatine compound with a hyperplastic inhibitory agent for inhibiting undesirable cell growth |
07/27/1995 | CA2181547A1 Hematopoietic cell expansion and transplantation methods |
07/27/1995 | CA2181431A1 Haemopoietic maturation factor |
07/25/1995 | US5435999 Cytokines for cell proliferation |
07/20/1995 | WO1995019448A1 Nucleic acid mutation detection in histologic tissue |
07/20/1995 | WO1995019434A1 Tissue-specific enhancer active in prostate |
07/20/1995 | WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides |
07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
07/20/1995 | WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication |
07/20/1995 | WO1995019375A1 Peptides and methods against psoriasis |
07/20/1995 | WO1995019183A1 Cd44 expression in smooth muscle cells |
07/20/1995 | WO1995019182A1 Somatic gene therapy to cells associated with fluid spaces |
07/20/1995 | WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis |
07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
07/20/1995 | CA2210396A1 Method for detection and treatment of breast cancer |
07/20/1995 | CA2181170A1 Somatic gene therapy to cells associated with fluid spaces |
07/20/1995 | CA2181147A1 Nucleic acid mutation detection in histologic tissue |
07/20/1995 | CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis |
07/20/1995 | CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication |
07/20/1995 | CA2180347A1 Anti-hepatitis b poly- and oligonucleotides |
07/20/1995 | CA2179391A1 Cd44 expression in smooth muscle cells |
07/20/1995 | CA2179280A1 Peptides and methods against psoriasis |
07/19/1995 | EP0663013A1 Method for delivering nucleic acids into cells |
07/19/1995 | EP0663008A1 Improvements in or relating to immune response modification |
07/19/1995 | EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
07/19/1995 | EP0662837A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
07/18/1995 | US5434086 Method of testing potential cystic fibrosis treating compounds using cells in culture |
07/18/1995 | US5433946 Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases |
07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
07/13/1995 | WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development |
07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
07/13/1995 | WO1995008631A3 Target antigens of transmission blocking antibodies for malaria parasites |
07/13/1995 | CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity |
07/12/1995 | EP0662140A1 Method of enhancing and/or prolonging expression of a gene introduced into a cell |
07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |
07/12/1995 | EP0662128A1 Methods and compositions for controlling translation of hcv proteins |
07/12/1995 | EP0662077A1 Cd27 ligand |
07/12/1995 | EP0662003A1 Oligonucleotide modulation of cell adhesion |
07/12/1995 | EP0661987A1 Morphogen-induced liver regeneration |
07/12/1995 | EP0661979A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation |
07/12/1995 | EP0661933A1 Morphogen-enriched dietary composition |
07/11/1995 | CA1336269C Expression of mammalian genes at high levels in host cells |
07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
07/06/1995 | WO1995018223A1 Gene expression control |
07/06/1995 | WO1995018221A1 Gene coding for adseverins |
07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
07/06/1995 | WO1995011984A3 Recombinant adenoviral vector and methods of use |